_id
6919e3be3c536f8df231804b
Ticker
4BB.LSE
Name
4BASEBIO UK SOCIETAS
Exchange
LSE
Address
25 Norman Way, Cambridge, United Kingdom, CB24 5QE
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://www.4basebio.com
Description
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally. The company offers hpDNA, double stranded linear DNA, covalently closed with single strand hairpins at the 5' and 3' ends for viral and non-viral vector applications; opDNA, a partially opened, linear, double stranded DNA product for in vitro transcription processes for the production of mRNA for use in vaccines and therapeutics; and oeDNA, or open ended DNA, a linear, double stranded DNA product ideal for genome editing. It also provides osDNA, or open stabilized DNA, a product incorporating nucleotide modifications within the DNA backbone enables tuning of the immunostimulatory properties of the construct for DNA vaccine applications; and The Hermes, a proprietary delivery platform for nucleic acid and protein payloads appears to offer a thermo-stable alternative to traditional lipid based delivery systems. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.
Last Close
6150000
Volume
1045
Current Price
606
Change
0
Last Updated
2025-12-29T14:55:22.164Z
Image
https://logo.clearbit.com/www.4basebio.com
Ipo Date
-
Market Cap
95231992
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
5
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
1174000
Cost Of Revenue
1048000
Gross Profit
126000
Operating Expenses
8356999
Operating Income
-8231000
Interest Expense
416000
Pretax Income
-8221999
Net Income
-7804000
Eps
-0.5038706811119065
Dividends Per Share
-
Shares Outstanding
15484875
Income Tax Expense
-418000
EBITDA
-7231000
Operating Margin
-701.1073253833049
Total Other Income Expense Net
9000
Cash
26114000
Short Term Investments
-
Receivables
113000
Inventories
529000
Total Current Assets
28702000
Property Plant Equipment
4353000
Total Assets
36871000
Payables
895000
Short Term Debt
131000
Long Term Debt
-
Total Liabilities
17887000
Equity
18984000
Bs_currency_symbol
GBP
Depreciation
575000
Change In Working Capital
-869000
Cash From Operations
-7641000
Capital Expenditures
322000
Cash From Investing
-642000
Cash From Financing
-269000
Net Change In Cash
-8490000
Cf_currency_symbol
-
PE
-
PB
494.40524683944375
ROE
-41.10830172777075
ROA
-21.16568576930379
FCF
-7963000
Fcf Percent
-6.7827938671209544
Piotroski FScore
1
Health Score
23
Deep Value Investing Score
2.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
4
Growth Investing Score
3
Momentum Investing Score
4
Net Net Investing Score
3
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1174000
Quarters > 0 > income Statement > cost Of Revenue
1048000
Quarters > 0 > income Statement > gross Profit
126000
Quarters > 0 > income Statement > operating Expenses
8356999
Quarters > 0 > income Statement > operating Income
-8231000
Quarters > 0 > income Statement > interest Expense
416000
Quarters > 0 > income Statement > pretax Income
-8221999
Quarters > 0 > income Statement > net Income
-7804000
Quarters > 0 > income Statement > eps
-0.5038706811119065
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
15488101
Quarters > 0 > income Statement > income Tax Expense
-418000
Quarters > 0 > income Statement > EBITDA
-7231000
Quarters > 0 > income Statement > operating Margin
-701.1073253833049
Quarters > 0 > income Statement > total Other Income Expense Net
9000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
26114000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
113000
Quarters > 0 > balance Sheet > inventories
529000
Quarters > 0 > balance Sheet > total Current Assets
28702000
Quarters > 0 > balance Sheet > property Plant Equipment
4353000
Quarters > 0 > balance Sheet > total Assets
36871000
Quarters > 0 > balance Sheet > payables
895000
Quarters > 0 > balance Sheet > short Term Debt
131000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
17887000
Quarters > 0 > balance Sheet > equity
18984000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-7804000
Quarters > 0 > cash Flow > depreciation
575000
Quarters > 0 > cash Flow > change In Working Capital
-869000
Quarters > 0 > cash Flow > cash From Operations
-7641000
Quarters > 0 > cash Flow > capital Expenditures
322000
Quarters > 0 > cash Flow > cash From Investing
-642000
Quarters > 0 > cash Flow > cash From Financing
-269000
Quarters > 0 > cash Flow > net Change In Cash
-8490000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.5038706811119065
Quarters > 0 > ratios > PB
494.40524683944375
Quarters > 0 > ratios > ROE
-41.10830172777075
Quarters > 0 > ratios > ROA
-21.16568576930379
Quarters > 0 > ratios > FCF
-7963000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-6.7827938671209544
Quarters > 0 > health Score
23
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
605000
Quarters > 1 > income Statement > cost Of Revenue
631000
Quarters > 1 > income Statement > gross Profit
-26000
Quarters > 1 > income Statement > operating Expenses
10830000
Quarters > 1 > income Statement > operating Income
-10856000
Quarters > 1 > income Statement > interest Expense
409000
Quarters > 1 > income Statement > pretax Income
-6512000
Quarters > 1 > income Statement > net Income
-6605000
Quarters > 1 > income Statement > eps
-0.5115059804768118
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
12912850
Quarters > 1 > income Statement > income Tax Expense
93000
Quarters > 1 > income Statement > EBITDA
-7952000
Quarters > 1 > income Statement > operating Margin
-1794.3801652892564
Quarters > 1 > income Statement > total Other Income Expense Net
4344000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
34604000
Quarters > 1 > balance Sheet > short Term Investments
225000
Quarters > 1 > balance Sheet > receivables
283000
Quarters > 1 > balance Sheet > inventories
374000
Quarters > 1 > balance Sheet > total Current Assets
36888000
Quarters > 1 > balance Sheet > property Plant Equipment
4326000
Quarters > 1 > balance Sheet > total Assets
44727000
Quarters > 1 > balance Sheet > payables
1694000
Quarters > 1 > balance Sheet > short Term Debt
188000
Quarters > 1 > balance Sheet > long Term Debt
14294000
Quarters > 1 > balance Sheet > total Liabilities
18347000
Quarters > 1 > balance Sheet > equity
26380000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-6605000
Quarters > 1 > cash Flow > depreciation
420000
Quarters > 1 > cash Flow > change In Working Capital
892000
Quarters > 1 > cash Flow > cash From Operations
-5564000
Quarters > 1 > cash Flow > capital Expenditures
509000
Quarters > 1 > cash Flow > cash From Investing
-876000
Quarters > 1 > cash Flow > cash From Financing
38331000
Quarters > 1 > cash Flow > net Change In Cash
31886000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.5115059804768118
Quarters > 1 > ratios > PB
296.63332448824866
Quarters > 1 > ratios > ROE
-25.037907505686125
Quarters > 1 > ratios > ROA
-14.767366467681715
Quarters > 1 > ratios > FCF
-6073000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-10.03801652892562
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
328000
Quarters > 2 > income Statement > cost Of Revenue
92000
Quarters > 2 > income Statement > gross Profit
236000
Quarters > 2 > income Statement > operating Expenses
6035000
Quarters > 2 > income Statement > operating Income
-5799000
Quarters > 2 > income Statement > interest Expense
343000
Quarters > 2 > income Statement > pretax Income
-6142000
Quarters > 2 > income Statement > net Income
-5728000
Quarters > 2 > income Statement > eps
-0.4506996506212188
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
12709129
Quarters > 2 > income Statement > income Tax Expense
-414000
Quarters > 2 > income Statement > EBITDA
-5468000
Quarters > 2 > income Statement > operating Margin
-1767.9878048780488
Quarters > 2 > income Statement > total Other Income Expense Net
-343000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
2718000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
52000
Quarters > 2 > balance Sheet > inventories
362000
Quarters > 2 > balance Sheet > total Current Assets
4922000
Quarters > 2 > balance Sheet > property Plant Equipment
4001000
Quarters > 2 > balance Sheet > total Assets
11928000
Quarters > 2 > balance Sheet > payables
795000
Quarters > 2 > balance Sheet > short Term Debt
220000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
17146000
Quarters > 2 > balance Sheet > equity
-5218000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-5728000
Quarters > 2 > cash Flow > depreciation
513000
Quarters > 2 > cash Flow > change In Working Capital
-89000
Quarters > 2 > cash Flow > cash From Operations
-5194000
Quarters > 2 > cash Flow > capital Expenditures
188000
Quarters > 2 > cash Flow > cash From Investing
-695000
Quarters > 2 > cash Flow > cash From Financing
5550000
Quarters > 2 > cash Flow > net Change In Cash
-351000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.4506996506212188
Quarters > 2 > ratios > PB
-1475.9931341510157
Quarters > 2 > ratios > ROE
109.77385971636642
Quarters > 2 > ratios > ROA
-48.02146210596915
Quarters > 2 > ratios > FCF
-5382000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-16.408536585365855
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
164000
Quarters > 3 > income Statement > cost Of Revenue
46000
Quarters > 3 > income Statement > gross Profit
118000
Quarters > 3 > income Statement > operating Expenses
3017500
Quarters > 3 > income Statement > operating Income
-2899500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-3071000
Quarters > 3 > income Statement > net Income
-2864000
Quarters > 3 > income Statement > eps
-0.2253498253106094
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
12709129
Quarters > 3 > income Statement > income Tax Expense
207000
Quarters > 3 > income Statement > EBITDA
-2734000
Quarters > 3 > income Statement > operating Margin
-1767.9878048780488
Quarters > 3 > income Statement > total Other Income Expense Net
-171500
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
2718000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
52000
Quarters > 3 > balance Sheet > inventories
362000
Quarters > 3 > balance Sheet > total Current Assets
4922000
Quarters > 3 > balance Sheet > property Plant Equipment
4001000
Quarters > 3 > balance Sheet > total Assets
11928000
Quarters > 3 > balance Sheet > payables
795000
Quarters > 3 > balance Sheet > short Term Debt
220000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
17146000
Quarters > 3 > balance Sheet > equity
-5218000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-2864000
Quarters > 3 > cash Flow > depreciation
256500
Quarters > 3 > cash Flow > change In Working Capital
-44500
Quarters > 3 > cash Flow > cash From Operations
-2570500
Quarters > 3 > cash Flow > capital Expenditures
94000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2748500
Quarters > 3 > cash Flow > net Change In Cash
-175500
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.2253498253106094
Quarters > 3 > ratios > PB
-1475.9931341510157
Quarters > 3 > ratios > ROE
54.88692985818321
Quarters > 3 > ratios > ROA
-24.010731052984575
Quarters > 3 > ratios > FCF
-2664500
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-16.246951219512194
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
933000
Annuals > 0 > income Statement > cost Of Revenue
303000
Annuals > 0 > income Statement > gross Profit
630000
Annuals > 0 > income Statement > operating Expenses
12672000
Annuals > 0 > income Statement > operating Income
-12042000
Annuals > 0 > income Statement > interest Expense
752000
Annuals > 0 > income Statement > pretax Income
-12654000
Annuals > 0 > income Statement > net Income
-12333000
Annuals > 0 > income Statement > eps
-0.940261059103104
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
13116570
Annuals > 0 > income Statement > income Tax Expense
-321000
Annuals > 0 > income Statement > EBITDA
-10969000
Annuals > 0 > income Statement > operating Margin
-1290.6752411575562
Annuals > 0 > income Statement > total Other Income Expense Net
-612000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
34604000
Annuals > 0 > balance Sheet > short Term Investments
225000
Annuals > 0 > balance Sheet > receivables
283000
Annuals > 0 > balance Sheet > inventories
374000
Annuals > 0 > balance Sheet > total Current Assets
36888000
Annuals > 0 > balance Sheet > property Plant Equipment
4326000
Annuals > 0 > balance Sheet > total Assets
44727000
Annuals > 0 > balance Sheet > payables
1694000
Annuals > 0 > balance Sheet > short Term Debt
188000
Annuals > 0 > balance Sheet > long Term Debt
14294000
Annuals > 0 > balance Sheet > total Liabilities
18347000
Annuals > 0 > balance Sheet > equity
26380000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-12333000
Annuals > 0 > cash Flow > depreciation
933000
Annuals > 0 > cash Flow > change In Working Capital
623000
Annuals > 0 > cash Flow > cash From Operations
-10744000
Annuals > 0 > cash Flow > capital Expenditures
1571000
Annuals > 0 > cash Flow > cash From Investing
-1571000
Annuals > 0 > cash Flow > cash From Financing
43867000
Annuals > 0 > cash Flow > net Change In Cash
31535000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.940261059103104
Annuals > 0 > ratios > PB
309.268633055345
Annuals > 0 > ratios > ROE
-46.751326762699016
Annuals > 0 > ratios > ROA
-27.57394862163794
Annuals > 0 > ratios > FCF
-12315000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-13.19935691318328
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
506000
Annuals > 1 > income Statement > cost Of Revenue
166000
Annuals > 1 > income Statement > gross Profit
340000
Annuals > 1 > income Statement > operating Expenses
8392000
Annuals > 1 > income Statement > operating Income
-8052000
Annuals > 1 > income Statement > interest Expense
302000
Annuals > 1 > income Statement > pretax Income
-8354000
Annuals > 1 > income Statement > net Income
-7665000
Annuals > 1 > income Statement > eps
-0.6221959580397215
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
12319270
Annuals > 1 > income Statement > income Tax Expense
-689000
Annuals > 1 > income Statement > EBITDA
-7343000
Annuals > 1 > income Statement > operating Margin
-1591.304347826087
Annuals > 1 > income Statement > total Other Income Expense Net
-302000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
3069000
Annuals > 1 > balance Sheet > short Term Investments
236000
Annuals > 1 > balance Sheet > receivables
107000
Annuals > 1 > balance Sheet > inventories
332000
Annuals > 1 > balance Sheet > total Current Assets
5022000
Annuals > 1 > balance Sheet > property Plant Equipment
4197000
Annuals > 1 > balance Sheet > total Assets
11922000
Annuals > 1 > balance Sheet > payables
694000
Annuals > 1 > balance Sheet > short Term Debt
392000
Annuals > 1 > balance Sheet > long Term Debt
9304000
Annuals > 1 > balance Sheet > total Liabilities
12414000
Annuals > 1 > balance Sheet > equity
-492000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-7665000
Annuals > 1 > cash Flow > depreciation
709000
Annuals > 1 > cash Flow > change In Working Capital
384000
Annuals > 1 > cash Flow > cash From Operations
-6178000
Annuals > 1 > cash Flow > capital Expenditures
1490000
Annuals > 1 > cash Flow > cash From Investing
-1490000
Annuals > 1 > cash Flow > cash From Financing
6425000
Annuals > 1 > cash Flow > net Change In Cash
-1282000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.6221959580397215
Annuals > 1 > ratios > PB
-15574.361666666666
Annuals > 1 > ratios > ROE
1557.9268292682927
Annuals > 1 > ratios > ROA
-64.29290387518873
Annuals > 1 > ratios > FCF
-7668000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-15.154150197628459
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
268000
Annuals > 2 > income Statement > cost Of Revenue
29000
Annuals > 2 > income Statement > gross Profit
239000
Annuals > 2 > income Statement > operating Expenses
6079000
Annuals > 2 > income Statement > operating Income
-5840000
Annuals > 2 > income Statement > interest Expense
89000
Annuals > 2 > income Statement > pretax Income
-5929000
Annuals > 2 > income Statement > net Income
-5150000
Annuals > 2 > income Statement > eps
-0.41810523960555873
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
12317473
Annuals > 2 > income Statement > income Tax Expense
-779000
Annuals > 2 > income Statement > EBITDA
-5409000
Annuals > 2 > income Statement > operating Margin
-2179.10447761194
Annuals > 2 > income Statement > total Other Income Expense Net
-89000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
4351000
Annuals > 2 > balance Sheet > short Term Investments
240000
Annuals > 2 > balance Sheet > receivables
54000
Annuals > 2 > balance Sheet > inventories
133000
Annuals > 2 > balance Sheet > total Current Assets
5897000
Annuals > 2 > balance Sheet > property Plant Equipment
3633000
Annuals > 2 > balance Sheet > total Assets
11689000
Annuals > 2 > balance Sheet > payables
490000
Annuals > 2 > balance Sheet > short Term Debt
415000
Annuals > 2 > balance Sheet > long Term Debt
2414000
Annuals > 2 > balance Sheet > total Liabilities
4569000
Annuals > 2 > balance Sheet > equity
7120000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-5150000
Annuals > 2 > cash Flow > depreciation
431000
Annuals > 2 > cash Flow > change In Working Capital
168000
Annuals > 2 > cash Flow > cash From Operations
-4704000
Annuals > 2 > cash Flow > capital Expenditures
1941000
Annuals > 2 > cash Flow > cash From Investing
-1941000
Annuals > 2 > cash Flow > cash From Financing
1244000
Annuals > 2 > cash Flow > net Change In Cash
-5235000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.41810523960555873
Annuals > 2 > ratios > PB
1076.0489053370788
Annuals > 2 > ratios > ROE
-72.3314606741573
Annuals > 2 > ratios > ROA
-44.058516554025154
Annuals > 2 > ratios > FCF
-6645000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-24.794776119402986
Annuals > 2 > health Score
22
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
338000
Annuals > 3 > income Statement > cost Of Revenue
69000
Annuals > 3 > income Statement > gross Profit
269000
Annuals > 3 > income Statement > operating Expenses
3796000
Annuals > 3 > income Statement > operating Income
-3527000
Annuals > 3 > income Statement > interest Expense
113000
Annuals > 3 > income Statement > pretax Income
-3640000
Annuals > 3 > income Statement > net Income
-3235000
Annuals > 3 > income Statement > eps
-0.2626350388590257
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
12317473
Annuals > 3 > income Statement > income Tax Expense
-405000
Annuals > 3 > income Statement > EBITDA
-3207000
Annuals > 3 > income Statement > operating Margin
-1043.491124260355
Annuals > 3 > income Statement > total Other Income Expense Net
-113000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
9586000
Annuals > 3 > balance Sheet > short Term Investments
228000
Annuals > 3 > balance Sheet > receivables
46000
Annuals > 3 > balance Sheet > inventories
156000
Annuals > 3 > balance Sheet > total Current Assets
10642000
Annuals > 3 > balance Sheet > property Plant Equipment
2759000
Annuals > 3 > balance Sheet > total Assets
14702000
Annuals > 3 > balance Sheet > payables
353000
Annuals > 3 > balance Sheet > short Term Debt
432000
Annuals > 3 > balance Sheet > long Term Debt
860000
Annuals > 3 > balance Sheet > total Liabilities
3007000
Annuals > 3 > balance Sheet > equity
11695000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-3235000
Annuals > 3 > cash Flow > depreciation
320000
Annuals > 3 > cash Flow > change In Working Capital
455000
Annuals > 3 > cash Flow > cash From Operations
-2740000
Annuals > 3 > cash Flow > capital Expenditures
1512000
Annuals > 3 > cash Flow > cash From Investing
-1512000
Annuals > 3 > cash Flow > cash From Financing
-467000
Annuals > 3 > cash Flow > net Change In Cash
-5415000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.2626350388590257
Annuals > 3 > ratios > PB
655.1063023514322
Annuals > 3 > ratios > ROE
-27.661393758016246
Annuals > 3 > ratios > ROA
-22.003809005577473
Annuals > 3 > ratios > FCF
-4252000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-12.579881656804734
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.5038706811119065
Valuation > metrics > PB
494.40524683944375
Valuation > final Score
20
Valuation > verdict
16380.2% Overvalued
Profitability > metrics > ROE
-41.10830172777075
Profitability > metrics > ROA
-27.189742875060972
Profitability > metrics > Net Margin
-6.647359454855196
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.9422144964180362
Risk > metrics > Interest Coverage
-19.786057692307693
Risk > final Score
-31
Risk > verdict
High
Liquidity > metrics > Current Ratio
27.97465886939571
Liquidity > metrics > Quick Ratio
27.45906432748538
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
-58
Prev Risks > 1
-38
Prev Risks > 2
-4
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:59:36.871Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-25
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-05-30
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.49
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.49
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-09-27
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.45
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.45
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-03-31
Earnings History > 3 > report Date
2023-05-11
Earnings History > 3 > date
2023-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
-0.22
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-09-30
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
-0.2
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-03-31
Earnings History > 5 > report Date
2022-06-09
Earnings History > 5 > date
2022-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.13
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.13
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-09-30
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.13
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.13
Earnings History > 6 > surprise Percent
-
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally. The company offers hpDNA, double stranded linear DNA, covalently closed with single strand hairpins at the 5' and 3' ends for viral and non-viral vector applications; opDNA, a partially opened, linear, double stranded DNA product for in vitro transcription processes for the production of mRNA for use in vaccines and therapeutics; and oeDNA, or open ended DNA, a linear, double stranded DNA product ideal for genome editing. It also provides osDNA, or open stabilized DNA, a product incorporating nucleotide modifications within the DNA backbone enables tuning of the immunostimulatory properties of the construct for DNA vaccine applications; and The Hermes, a proprietary delivery platform for nucleic acid and protein payloads appears to offer a thermo-stable alternative to traditional lipid based delivery systems. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Rating:
STRONG BUY
$
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of 4BASEBIO UK SOCIETAS
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-03-31
EPS Actual
-0.49
EPS Estimate
0
EPS Difference
-0.49
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.